Deslorelin | CAS:57773-65-6

We serve Deslorelin CAS:57773-65-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Deslorelin

Chemical Name:Deslorelin
CAS.NO:57773-65-6
Synonyms:Deslorelin
deslorelin acetate
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 1783.4ºC at 760 mmHg
Molecular Formula C64H83N17O12
Molecular Weight 1282.450
Flash Point 1032.4ºC
Index of Refraction 1.710
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Deslorelin Acetate (brand name Ovuplant) is currently approved for use in veterinary medicine and is used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock.



Contact us for information like Deslorelin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,deslorelin acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,deslorelin acetate Use and application,deslorelin acetate technical grade,usp/ep/jp grade.


Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.2-Bromo-4'-nitroacetophenone manufacturer The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.Diethyl Oxalacetate supplier The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride vendor The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China.